NCT01419938

Brief Summary

Delayed sleep phase syndrome (DSPS) is the most common of the circadian rhythm sleep disorders (CRSD). A person with DSPS have sufficient sleep quality, but their circadian clock is delayed compared to the normal 24-h period. They fall asleep around 03.00-04.00 at night and sleeps until 02.00-03.00 in the afternoon. This syndrome is most frequent among young people between 16-25 years, which conveys that school attendance and education are affected, and also often results in severe social consequences. DSPS is sometimes associated with depression and personality disorders and may aggravate psychiatric symptoms. This syndrome is highly underdiagnosed and there are no detailed guidelines how to treat it. The treatment usually consists of light therapy, chronotherapy or melatonin. There is a lack of guidelines how often, with which wavelength, and how long the treatment of DSPS patients shall go on. Previous studies shows that light therapy often is effective. The effect gets even better if melatonin is administered concurrently. However, the frequency of relapse is high. Thus, DSPS is a prevalent syndrome in young adults with severe consequences on normal daytime functioning. There are almost no treatment options available in health care settings. There is a clear need for further studies on this topic. The main purpose of the present study is to evaluate the clinical effects of short and long-term treatment by using light therapy and cognitive behaviour therapy (CBT). CBT is recommended at mild to moderate depression and anxiety. It also has some evidence in treating insomnia. Patients with DSPS often have al of these symptoms and therefore the investigators would like to investigate if CBT can enhance the effect of light therapy. Firstly, the investigators want to evaluate the short-term effects of light therapy with and without CBT. Secondly, the investigators want to evaluate if the patients who get CBT maintain a "normal" sleep rhythm and prevent relapse of DSPS compared to just light therapy for two weeks. The investigators also want to evaluate how this patient-group differs when it comes to behavioral factors compared to a matched reference group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2011

Completed
6 days until next milestone

Study Start

First participant enrolled

August 1, 2011

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 18, 2011

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2013

Completed
Last Updated

April 25, 2013

Status Verified

April 1, 2013

Enrollment Period

1.7 years

First QC Date

July 26, 2011

Last Update Submit

April 24, 2013

Conditions

Keywords

Light therapycircadian rhythmCBT

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in sleep-diary at 6 months.

    That the patients will go to bed before 01:00 and wake up not later than 09:00 a.m. or earlier.

    Change from baseline in sleep-diary at 6 months.

Secondary Outcomes (16)

  • Changes from baseline in sleep-diary at 6 weeks.

    Changes from baseline in sleep diary at 6 weeks.

  • Change from baseline in Hospital anxiety-depression scale at 2 weeks

    Change from baseline in Hospital anxiety-depression scale at 2 weeks

  • Change from baseline in Hospital anxiety-depression scale at 6 weeks

    Change from baseline in Hospital anxiety-depression scale at 6 weeks

  • Change from baseline in Hospital anxiety-depression scale at 6 months

    Change from baseline in Hospital anxiety-depression scale at 6 months

  • Change from baseline in Insomnia Severity Scale at 2 weeks

    Change from baseline in Insomnia Severity Scale at 2 weeks

  • +11 more secondary outcomes

Other Outcomes (3)

  • Does DLMO correlate with sleep diary

    baseline

  • Is DLMO important for setting the time to start light therapy

    From baseline to 2 weeks

  • Is scores in MEQ important to decide when to start light therapy in the morning.

    from baseline to 2 weeks of Light therapy

Study Arms (2)

Light therapy for two weeks

ACTIVE COMPARATOR
Device: Light therapy

Light therapy and CBT

ACTIVE COMPARATOR

Two weeks of light therapy and after that 4 weeks of Cognitive behaviour therapy (CBT)

Device: Light therapy and Cognitive behaviour therapy

Interventions

Light therapy every morning during 30 minutes for two weeks. CBT for 90 to 120 minutes weekly during four weeks.

Light therapy and CBT

Light therapy every morning during 30-45 minutes for two weeks.

Light therapy for two weeks

Eligibility Criteria

Age16 Years - 26 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Clinical diagnosis of delayed sleep phase syndrome.

You may not qualify if:

  • Eye diseases
  • Active psychiatric disorder.
  • Ongoing somatic disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep department

Uppsala, 75185, Sweden

Location

Related Publications (4)

  • Benloucif S, Burgess HJ, Klerman EB, Lewy AJ, Middleton B, Murphy PJ, Parry BL, Revell VL. Measuring melatonin in humans. J Clin Sleep Med. 2008 Feb 15;4(1):66-9.

    PMID: 18350967BACKGROUND
  • Gooley JJ. Treatment of circadian rhythm sleep disorders with light. Ann Acad Med Singap. 2008 Aug;37(8):669-76.

    PMID: 18797560BACKGROUND
  • Bjorvatn B, Pallesen S. A practical approach to circadian rhythm sleep disorders. Sleep Med Rev. 2009 Feb;13(1):47-60. doi: 10.1016/j.smrv.2008.04.009. Epub 2008 Oct 8.

    PMID: 18845459BACKGROUND
  • Dagan Y, Yovel I, Hallis D, Eisenstein M, Raichik I. Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS). Chronobiol Int. 1998 Mar;15(2):181-90. doi: 10.3109/07420529808998682.

    PMID: 9562922BACKGROUND

MeSH Terms

Conditions

Sleep Disorders, Circadian Rhythm

Interventions

Phototherapy

Condition Hierarchy (Ancestors)

Chronobiology DisordersNervous System DiseasesDyssomniasSleep Wake DisordersOccupational DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

  • Katarina ML Danielsson, M.D.

    Sleep department, Uppsala University Hospital, Sweden

    PRINCIPAL INVESTIGATOR
  • Agneta Markstroem, Ass. Prof.

    Sleep department, Uppsala University Hospital, Sweden

    PRINCIPAL INVESTIGATOR
  • Jan-Erik Broman, Ass. Prof.

    Sleep department, Uppsala University Hospital, Sweden

    PRINCIPAL INVESTIGATOR
  • Markus Jansson-Fröjmark, Ass. Prof.

    Department of Psychology, Stockholm University, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. Ph.D student.

Study Record Dates

First Submitted

July 26, 2011

First Posted

August 18, 2011

Study Start

August 1, 2011

Primary Completion

April 1, 2013

Study Completion

April 1, 2013

Last Updated

April 25, 2013

Record last verified: 2013-04

Locations